Published in
Springer (part of Springer Nature), Cancer Chemotherapy and Pharmacology, 3(82), p. 419-419
DOI: 10.1007/s00280-018-3641-5
Links
Tools
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Journal article published in 2018 by
Amita Patnaik,
Michael Gordon,
Frank Tsai,
Kyriakos P. Papadopoulos 
,
Drew Rasco,
Muralidhar Beeram,
Siqing Fu ,
Filip Janku ,
Scott M. Hynes,
Sushma R. Gundala ,
Melinda D. Willard,
Wei Zhang,
Aimee Bence Lin,
David Hong
,
Drew Rasco,
Muralidhar Beeram,
Siqing Fu ,
Filip Janku ,
Scott M. Hynes,
Sushma R. Gundala ,
Melinda D. Willard,
Wei Zhang,
Aimee Bence Lin,
David Hong
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 